Comments
Loading...

Salarius Pharmaceuticals

SLRXNASDAQ
Logo brought to you by Benzinga Data
$1.55
0.149.93%
At close: -
$1.51
-0.04-2.58%
After Hours: Dec 20, 6:19 PM EDT

Salarius Pharmaceuticals (NASDAQ:SLRX) Stock, Earnings Estimates, EPS, And Revenue

Salarius Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 14
EPS
$-0.760
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)

Analyze the earnings history of Salarius Pharmaceuticals using advanced sorting and filters.

Data brought to you by Benzinga APIs

Salarius Pharmaceuticals (SLRX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-14$-0.76$-2.4068.3 %
Jun 20242024-08-09$-2.37$-53.6095.6 %
Mar 20242024-05-13$-3.28$-53.6093.9 %
Dec 20232024-03-22$-1.76$-8.0878.2 %

Salarius Pharmaceuticals (SLRX) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Dec 20212022-03-10$0$430.00K-100.0 %
Sep 20212021-11-04$0$1.16M-100.0 %
Jun 20212021-08-05$571.39K$1.28M-55.4 %
Mar 20212021-05-12$1.27M$1.37M-7.37 %

FAQ

Q

When is Salarius Pharmaceuticals (NASDAQ:SLRX) reporting earnings?

A

Salarius Pharmaceuticals (SLRX) is scheduled to report earnings on March 21, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Salarius Pharmaceuticals (NASDAQ:SLRX)?

A

The Actual EPS was $-0.76, which beat the estimate of $-2.40.

Q

What were Salarius Pharmaceuticals’s (NASDAQ:SLRX) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch